ArticleScientific reports2025
Developing 400 MPa grade biodegradable Zn alloys with superior osteogenic and antibacterial performance.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanical Properties and Corrosion Behavior of Biodegradable Metals: Current Challenges.Materials (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biodegradable zinc (Zn) has emerged as a promising orthopedic implant material, capable of supporting bone repair while gradually resorbing in the body. Yet, its relatively low strength has restricted its use in high load-bearing scenarios. The addition of lithium (Li) improves mechanical strengths of Zn alloys, of which are comparable to that of pure Ti. Here, we present a Zn-0.8Li alloy system enhanced through alloying and equal channel angular pressing (ECAP). By tuning the processing temperature, the alloys attained superior mechanical performance, with tensile strength reaching 434 MPa and elongation of 65% at 200 °C. The dominant strengthening mechanisms were identified as grain boundary strengthening and dislocation strengthening. Corrosion assessment revealed a stable degradation rate of ~ 5.5 μm/year after 30 days of immersion, with localized attack at second phases and grain boundary corrosion in ultrafine-grained microstructures (T-150 and T-200 samples), whereas a fine-grained microstructure (T-300 sample) exhibited suppressed boundary corrosion. In vitro studies confirmed excellent cytocompatibility and osteogenic potential of the ECAP-treated Zn-0.8Li alloys compared with bioinert Ti. Furthermore, antibacterial tests demonstrated inhibition rates exceeding 90% against E. coli colonies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.